PTC Therapeutics, Inc. announced the promotion of Dr. Mark Pykett to Chief Scientific Officer and Dr. Neil Almstead to Chief Technical Operations Officer. Mark Pykett, V.M.D., Ph.D., has been promoted to Chief Scientific Officer, a role in which he leads the research initiatives of PTC. Neil Almstead has been promoted to the newly created position of Chief Technical Operations Officer. In this role, he is responsible for manufacturing and supply chain for both the small molecule programs, as well as the gene therapy platform.